An in-depth look to MYUNGMOON PHARM operating, investing, and financing activities

017180 free cash flow for Q2 24 is 785.23 M KRW. For 2023, 017180 free cash flow was -8.16 B KRW and operating cash flow was -5.18 B KRW.